Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tripti Shrivastava

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
The Plant Cell|July 22, 2025
Arabidopsis GELP53 overexpression modulates polysaccharide acetylation and defense through oligosaccharide-mediated signalingLavi Rastogi, Muhammad-Moazzam Hussain, Shivangi Tyagi, et al.
3 Biotech|August 5, 2022
Characterization of a broadly cross reactive tetravalent human monoclonal antibody, recognizing conformational epitopes in receptor binding domain of SARS-CoV-2Sonal Garg, Nisha Raj, Asha Lukose, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|October 19, 2013
Comparison of cystatin C and Beta-2-microglobulin kinetics in children on maintenance hemodialysisOlivera Marsenic, Andrea Wierenga, Donna R Wilson, et al.
Journal of Virology|January 15, 2016
Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 LoopShilpa Patil, Rajesh Kumar, Suprit Deshpande, et al.
Elife|January 11, 2022
Golden Syrian hamster as a model to study cardiovascular complications associated with SARS-CoV-2 infectionZaigham Abbas Rizvi, Rajdeep Dalal, Srikanth Sadhu, et al.
Iscience|October 1, 2025
Comparison of immunogenicity and protection efficacy of self-amplifying and circular mRNA vaccines against SARS-CoV-2Oinam Ningthemmani Singh, Umang Berry, Garima Joshi, et al.
International Immunopharmacology|October 14, 2021
The SARS CoV-2 spike directed non-neutralizing polyclonal antibodies cross-react with Human immunodeficiency virus (HIV-1) gp41Reshma Perween, Murugavelu PraveenKumar, Tripti Shrivastava, et al.
Frontiers in Microbiology|February 8, 2021
Development of a Fast SARS-CoV-2 IgG ELISA, Based on Receptor-Binding Domain, and Its Comparative Evaluation Using Temporally Segregated Samples From RT-PCR Positive IndividualsFarha Mehdi, Souvick Chattopadhyay, Ramachandran Thiruvengadam, et al.
International Immunopharmacology|August 24, 2021
Non-neutralizing SARS CoV-2 directed polyclonal antibodies demonstrate cross-reactivity with the HA glycans of influenza virusPraveenkumar Murugavelu, Reshma Perween, Tripti Shrivastava, et al.
Nature Microbiology|June 10, 2022
Inactivated whole-virion vaccine BBV152/Covaxin elicits robust cellular immune memory to SARS-CoV-2 and variants of concernRajesh Vikkurthi, Asgar Ansari, Anupama R Pai, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
The Plant Cell|July 22, 2025
Arabidopsis GELP53 overexpression modulates polysaccharide acetylation and defense through oligosaccharide-mediated signalingLavi Rastogi, Muhammad-Moazzam Hussain, Shivangi Tyagi, et al.
3 Biotech|August 5, 2022
Characterization of a broadly cross reactive tetravalent human monoclonal antibody, recognizing conformational epitopes in receptor binding domain of SARS-CoV-2Sonal Garg, Nisha Raj, Asha Lukose, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|October 19, 2013
Comparison of cystatin C and Beta-2-microglobulin kinetics in children on maintenance hemodialysisOlivera Marsenic, Andrea Wierenga, Donna R Wilson, et al.
Journal of Virology|January 15, 2016
Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 LoopShilpa Patil, Rajesh Kumar, Suprit Deshpande, et al.
Elife|January 11, 2022
Golden Syrian hamster as a model to study cardiovascular complications associated with SARS-CoV-2 infectionZaigham Abbas Rizvi, Rajdeep Dalal, Srikanth Sadhu, et al.
Iscience|October 1, 2025
Comparison of immunogenicity and protection efficacy of self-amplifying and circular mRNA vaccines against SARS-CoV-2Oinam Ningthemmani Singh, Umang Berry, Garima Joshi, et al.
International Immunopharmacology|October 14, 2021
The SARS CoV-2 spike directed non-neutralizing polyclonal antibodies cross-react with Human immunodeficiency virus (HIV-1) gp41Reshma Perween, Murugavelu PraveenKumar, Tripti Shrivastava, et al.
Frontiers in Microbiology|February 8, 2021
Development of a Fast SARS-CoV-2 IgG ELISA, Based on Receptor-Binding Domain, and Its Comparative Evaluation Using Temporally Segregated Samples From RT-PCR Positive IndividualsFarha Mehdi, Souvick Chattopadhyay, Ramachandran Thiruvengadam, et al.
International Immunopharmacology|August 24, 2021
Non-neutralizing SARS CoV-2 directed polyclonal antibodies demonstrate cross-reactivity with the HA glycans of influenza virusPraveenkumar Murugavelu, Reshma Perween, Tripti Shrivastava, et al.
Nature Microbiology|June 10, 2022
Inactivated whole-virion vaccine BBV152/Covaxin elicits robust cellular immune memory to SARS-CoV-2 and variants of concernRajesh Vikkurthi, Asgar Ansari, Anupama R Pai, et al.
Pageof 6